NKE
43
-6
M
59
-2
ICE
67
-2
MSI
35
-3
MOS
50
8
MAT
45
-7
JCI
51
-6
EMN
62
-3
FLS
53
-15
BF.B
59
-2
MAS
60
-2
CAT
70
-9
A
43
-3
KSS
52
-4
EXPD
37
-5
AMP
73
-3
WMB
48
-4
DVA
52
-2
PCG
66
5
STZ
55
-2
NKE
43
-6
M
59
-2
ICE
67
-2
MSI
35
-3
MOS
50
8
MAT
45
-7
JCI
51
-6
EMN
62
-3
FLS
53
-15
BF.B
59
-2
MAS
60
-2
CAT
70
-9
A
43
-3
KSS
52
-4
EXPD
37
-5
AMP
73
-3
WMB
48
-4
DVA
52
-2
PCG
66
5
STZ
55
-2
Financhill
Back

Crombie Real Estate Investment Trust Vs. Nektar Therapeutics Industry Stock Comparison

Sell
17

CRR.UN.TO
Crombie Real Estate Investment Trust

Last Price:
$15.34
Seasonality Move:
0.77%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$53.42
Seasonality Move:
11.58%
Sell
17
Crombie Real Estate Investment Trust (CRR.UN.TO) is a Sell

Is Crombie Real Estate Investment Trust a Buy, Sell or Hold?

  • The current Crombie Real Estate Investment Trust [CRR.UN.TO] share price is $15.15. The Score for CRR.UN.TO is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • CRR.UN.TO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRR.UN.TO Stock Price Chart

What is Crombie Real Estate Investment Trust's stock price today?

  • The Crombie Real Estate Investment Trust share price today is $15.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRR.UN.TO is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

CRR.UN.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 49.03 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.1 - 15.36) Sell
Bollinger Bands (100): (14.81 - 15.29) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

CRR.UN.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.09 Buy
20-day SMA: 15.23 Sell
50-day SMA: 15.18 Sell
200-day SMA: 14.79 Buy
8-day EMA: 15.13 Buy
20-day EMA: 15.17 Sell
50-day EMA: 14.82 Buy
200-day EMA: 9.26 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Crombie Real Estate Investment Trust Earnings Growth & CRR.UN.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.01 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Crombie Real Estate Investment Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):